European Health Management Association (EHMA) is currently working on the production of a White Paper providing evidence-based policy insights into the management and prevention of the respiratory syncytial virus (RSV) infection in Europe. EHMA is reaching out to healthcare providers in Europe to survey their views on the RSV-associated burden and disruption to the healthcare system. EHMA has designed four structured questionnaires, addressing each of the care settings utilised by pediatric RSV patients: primary care, emergency medical services, pediatric general wards, and pediatric intensive care.
RSV is a leading cause of acute lower respiratory tract infections in children and a major contributor to the winter pressures that burdens healthcare organisations. Every winter, European healthcare organisations face a surge in demand for hospitals and outpatient services, and significant concerns around the nosocomial transmission of respiratory pathogens, e.g. RSV and influenza. This year, the seasonal strain on the healthcare system is likely to be compounded by a new wave of COVID-19 cases and healthcare authorities and providers remain poised to deal with a higher than average peak in winter respiratory pathogens.
To support optimal immunisation strategies for the prevention and control of RSV infection in the future, it is important to understand the system-wide pressures that affect health system performance in the peak RSV season and gather data on the treatment, management and burden of RSV in the community and hospital care.
EHMA is surveying healthcare providers in Europe to gather their views on the system performance and pressures in the peak RSV season, and the actions required to mitigate the effects of RSV-associated health system disruption. Four short structured questionnaires (maximum 20 minutes) are addressing each of the care settings utilised by pediatric RSV patients:
The information gathered will be published in a White Paper providing evidence-based policy insights into the management and prevention of RSV infection in Europe, and assist decision-makers, health managers and other stakeholders take a long-term preventive approach for the future.
If you have any questions or concerns about these questionnaires, please contact Dr Sanchari Dutta at email@example.com.